PURE BIOSCIENCE, INC.
EL CAJON, CA · Founded 2011 · CIK 0001006028 · Biotech
Antimicrobial compounds and surface treatments for food safety and contamination control
purebio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $29M
- 15 Form D · Feb 2017
- 117 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20102011201220132014201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,376,000 | |
| Private capital raised | Form D · SEC | $225,000 | |
| Private capital raised | Form D · SEC | $650,250 | |
| Private capital raised· 1 of 4 same day | Form D · SEC | $1,100,000 | |
| Private capital raised· 2 of 4 same day | Form D · SEC | $650,250 | |
| Private capital raised· 3 of 4 same day | Form D · SEC | $400,000 | |
| Private capital raised· 4 of 4 same day | Form D · SEC | $55,000 | |
| Private capital raised | Form D · SEC | $2,421,780 | |
| Private capital raised | Form D · SEC | $1,180,000 | |
| Private capital raised | Form D · SEC | $1,125,000 | |
| Private capital raised | Form D · SEC | $9,946,996 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $337,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3334 | HOUSEY PHARMACEUTICAL RESEARCH LAB | — | — |
| 3335 | Alpha-9 Oncology | — | — |
| 3336 | ABBRATECH INC. | — | — |
| 3337 | PURE BIOSCIENCE, INC. | — | $29M |
| 3338 | Timberlyne Therapeutics | — | — |
| 3339 | POP Biotechnologies Inc. | — | — |
| 3340 | SiMPore, Inc. | — | $1.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Gregory BarnhillDirector
- Dennis BrovaroneDirector
- Andrew BucklandExecutive Officer
- John CarboneDirector
- John Carbone, MDDirector
- Gary CoheeDirector
- Craig CulverDirector
- Mark ElliottExecutive Officer
- Craig JohnsonExecutive Officer
- Michael KrallDirector · Executive Officer
- Henry LambertDirector · Executive Officer
- Tom LeeDirector
- Paul MaierDirector
- William OtisDirector
- Dave PfanzelterDirector · Executive Officer
- Donna SingerDirector · Executive Officer
- David Theno, Jr.Director
- Peter WulffExecutive Officer
Patents
- Method And Device For Sanitizing Low Moisture Environmentsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.